Online Education

17CE069 - Genetics of Hemophilia

The purpose of this activity is to enable the learner to gain detailed knowledge about the genetics of hemophilia types A and B, to include testing, prevalence, genotypes and phenotypes, and inheritance patterns.

• Discuss the primary purpose for undergoing genetic testing in hemophilia
• Compare the prevalence rates of hemophilia A versus hemophilia B
• Describe the two main inversions that cause hemophilia A
• Explain how a point mutation can lead to hemophilia
• Assess the mechanism by which hemophilia and type 2N von Willebrand disease have the same phenotype
• Explain the most common mutations seen in hemophilia B
• Discuss how hemophilia B Leyden patients can become clotting factor independent in early adulthood
• Examine why some female carriers of hemophilia have bleeding symptoms and some do not
• Explore the mechanism by which two unrelated males share the same disease severity

The target audience for this presentation includes nurses and other health care professionals who are part of a U.S. hemophilia treatment center, or HTC, who are interested in learning more about the genetics of hemophilia.

This module will describe the primary purpose for undergoing genetic testing in hemophilia and the relationship between type of genetic mutation and disease severity.

• Anne Goodeve, PhD

June 20, 2017

5:00 PM Eastern, June 20, 2018

The estimated time to complete this activity is 60 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

This activity is provided for 1.0 contact hours under ANCC criteria.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education has been awarded Accreditation with Distinction, the highest recognition awarded by the American Nurses Credentialing Center's Accreditation Program. This distinction is valid through 2020.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

18CE071 - Understanding Hemophilia

The purpose of this activity is to introduce the learner to the basic aspects of hemophilia, including the deficit that interferes with formation of the stable fibrin clot, different types and severity levels of hemophilia, the inheritance pattern and special considerations for persons who are carriers of the gene, and the basic laboratory tests used to diagnose hemophilia.

• Define hemostasis and its three major processes
• Explain the deficit in hemophilia that interferes with formation of a stable fibrin clot
• Construct a diagram explaining sex-linked genetics of hemophilia
• Distinguish predicted bleeding patterns and clinical presentation based upon a classification of hemophilia as severe, moderate or mild
• Determine target factor levels for hemarthroses and muscle bleeds, major bleeds, and surgical management of hemophilia
• Differentiate hemophilia treatment methods including the four types of prophylaxis
• Discuss nursing considerations to be made when administering clotting factor products to patients
• Relate introductory information regarding factor XI deficiency

Nurses and other clinical staff within the federally recognized U.S. hemophilia treatment center (HTC) network who wish to expand their understanding of basic concepts of hemophilia

This module explores the three major steps in normal hemostasis, with particular emphasis on the key components of normal fibrin clot formation; and illustrates the coagulation cascade in an animated model. The module examines many basic aspects of hemophilia, including the deficit that interferes with formation of the stable fibrin clot, the different types and severity levels of hemophilia, the inheritance pattern and special considerations for persons who are carriers of the gene, and the basic laboratory tests used to diagnose hemophilia. Finally, the module describes in depth the treatment and management recommendations for different complications associated with each clinical severity level of hemophilia.

• Jennifer Maahs, MSN, PNP, RN-BC
• Amy Shapiro, MD

May 15, 2018

5:00 PM Eastern, May 15, 2019

The estimated time to complete this activity is 1 hour. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is provided for 1.0 contact hours under ANCC criteria.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education has been awarded Accreditation with Distinction, the highest recognition awarded by the American Nurses Credentialing Center's Accreditation Program. This distinction is valid through 2020.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

18CE068 - The 340B Pharmacy Program and the HTC

The Veterans Health Care Act of 1992 designated federally-recognized and -funded Hemophilia Diagnostic and Treatment Centers (HTCs) as covered entities eligible to participate in the 340B Drug Pricing Program. HTCs were henceforth able to utilize the 340B Program to stretch federal grant funding and develop capacity to provide robust, comprehensive services to all patients served. In 2015 federal grants divided among 140+ HTCs in the U.S. totaled only $4.9 million from Health Resources and Services Administration (HRSA) (to be used for services not covered by insurance) and an additional $5 million from the Centers for Disease Control and Prevention (CDC) (earmarked for surveillance and research).1 Thus, in this era of fiscal constraint brought on by budget cuts and the effects of federal sequestration, HTC participation in the 340B Pharmacy Program has provided a critical means of financial support for HTC services enabling provision of comprehensive care for all patients seen at HTCs with these programs. Approximately 100 of the 140 HTCs participate in the 340B Pharmacy Program.2 As a condition of participation, these centers must invest all revenues from the program back into patient services, care coordination, research and other programs that directly benefit patients. The purpose of this module is to examine the 340B Pharmacy Program, its role in homecare of hemophilia, eligibility and enrollment, restrictions and requirements, and special considerations for operation of such a program.

• Explain homecare provision and the role of the 340B Pharmacy Program
• Introduce Section 340B of the Veterans Health Care Act
• Define 340B Pharmacy Program eligibility and enrollment
• Identify restrictions and requirements to operate a 340B Pharmacy Program
• Discuss special considerations of operating a 340B Pharmacy Program at a federally-recognized U.S. Hemophilia Treatment Center (HTC)

Nurses, pharmacists, pharmacy technicians, and multidisciplinary providers in the U.S. Hemophilia Treatment Center (HTC) Network who wish to learn more about establishing and/or managing a 340B Pharmacy Program and the role of these programs in the U.S. HTC Network

This module will provide a brief history of the 340B Pharmacy Program established in 1992 under the Veterans Healthcare Act and the role of these programs in lowering costs of care and providing revenue for the HTC which must be reinvested into programs and services provided directly to HTC patients. For those HTCs in consideration of starting a 340B Pharmacy Program, this module also introduces the Office of Pharmacy Affairs requirements and regulations for such a program, including definitions of key terms and information about the application process, program maintenance, and potential program audits. Finally, this module will recommend the Hemophilia Alliance as a resource for HTCs with 340B Pharmacy Programs as well as those who are interested in learning more about the operation and management of such programs at HTCs.

• Jeff Blake, MBA, CEBS
• Madhu Koneru, PharmD

May 22, 2018

5:00 PM Eastern, May 22, 2019

The estimated time to complete this activity is 30 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is provided for 0.5 contact hours under ANCC criteria.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

17CE108 - Adherence to Prophylaxis in Hemophilia

Nonadherence to treatment regimen is a prevalent problem of patients with chronic disorders. It is estimated that approximately half of the patients with a chronic disease have problems following their prescribed regimen to the extent that they are unable to obtain optimal clinical benefit. This learning activity explores issues relating to treatment adherence in hemophilia. Topics include the current guidelines regarding prophylactic treatment of hemophilia, a quantification and definition of treatment adherence, an exploration of studies measuring adherence in hemophilia, quantitative measures of adherence, barriers to treatment adherence, methods to increase adherence, and issues of adherence with extended half-life products.

• Discuss current guidelines regarding prophylactic treatment of hemophilia
• Quantify prophylactic prescription rates in the U.S. and internationally
• Define treatment adherence
• Explore studies measuring adherence to prophylactic factor replacement in hemophilia
• Interpret quantitative measures of adherence including VERITAS-Pro
• Identify three barriers to prophylactic treatment of hemophilia
• Describe patient-oriented and provider initiated methods to increase patient adherence
• Explore issues of adherence to regimens utilizing extended half-life products

Health care professionals, including nurses, nurse practitioners, physical therapists, and social workers practicing at federally-funded hemophilia treatment centers (HTCs) and treating patients who utilize prophylactic factor replacement to treat hemophilia.

This module will review current guidelines regarding prophylactic treatment of hemophilia. It will take a close look at the different definitions of adherence and use the VERITAS-Pro to interpret quantitative measures. Finally, the module will show different methods to increase patient adherence.

• Natalie Duncan, MPH
• Katie Khair, PhD
• Courtney Thornburg, MD, MS

November 20, 2017

5:00 PM Eastern, November 20, 2018

The estimated time to complete this activity is 30 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.5 contact hours under ANCC criteria.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education has been awarded Accreditation with Distinction, the highest recognition awarded by the American Nurses Credentialing Center's Accreditation Program. This distinction is valid through 2020.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation (ANCC) through the joint providership of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education (UNMC CON CNE) (provider) and Partners in Bleeding Disorders Education.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

17CE107 - Improving Access to Care Through Outreach

The purpose of this activity is to explore the importance of access to care and evaluate common barriers to care faced by patients. We will introduce outreach as a model of care, including telemedicine, and review logistical and cost considerations associated with planning an outreach clinic. Two detailed case studies will enable the learner to apply information gained through this activity.

• List four potential barriers to care in vulnerable populations
• Define outreach as it relates to health care delivery
• Differentiate three telemedicine delivery methods
• Discuss considerations involved in planning and financing an outreach clinic
• Summarize the current consensus on the cost-effectiveness of outreach efforts
• Identify current barriers to care, appropriate interventions, and associated outcomes related to a review of detailed patient scenarios

This activity is intended for staff employed within the U.S Hemophilia Treatment Center Network, or USHTCN, to include nurses, social workers, physicians, physical therapists, administrators, and other professionals who wish to understand outreach as it relates to care in vulnerable populations. The activity may also be of interest to hospital or institutional staff responsible for planning and managing outreach programs.

This module describes how the approaches to using outreach clinics may help overcome challenges to the delivery of specialty medical care to individuals with bleeding disorders.
The presenters will review the barriers to patients (geographic, cultural, economic) as well as hemophilia treatment centers (administrative, cost, credentialing) that HTC staff must consider when initiating or maintaining an outreach program.

• Marcia L. Bird, LMSW, MSW
• Brenda Riske, RN, MSN, MBA, MPA
• Brian M. Wicklund, MDCM, MPH

February 20, 2018

5:00 PM Eastern February 28, 2019

The estimated time to complete this activity is 60 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 80% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 1.0 contact hour under ANCC criteria.

This program is Approved by the National Association of Social Workers (Approval #886604222-2203) for 1 continuing education contact hours.

The Indiana Hemophilia and Thrombosis Center/Partners PRN is an approved provider of continuing social work education by the National Association of Social Workers (Provider #886604222).

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

Hemophilia 101 for Nonclinical Staff at HTCs (non CE)

This module is designed to provide information about the U.S. federally funded hemophilia treatment center (or HTC) network (referred to as USHTCN) and the multidisciplinary comprehensive care provided at HTCs. The module also reviews the key concepts of data collection and research at HTCs. Providing an overview of the scientific precepts of hemophilia, the module further explains how data and clinical care are integrated and pertinent to the important role of nonclinical staff at HTCs.

• Identify different parts of the federally funded U.S. HTC network
• Examine key components of the hemophilia comprehensive care model
• Review data collection requirements for linking the comprehensive care model to health outcomes
• Explain general scientific precepts of bleeding disorders
• Evaluate how data and clinical care are integrated and pertinent to the role of nonclinical staff

This module is designed for nonclinical professionals in the HTC network, including data collection personnel, administrators, HTC staff interacting with 340B programs.

This module is divided into three sections:
Section I covers the U.S. Hemophilia Treatment Center Network (USHTCN) and the multidisciplinary comprehensive care model practiced at HTCs,
Section II reviews the data collection and research at HTCs, and
Section III discusses the clinical and medical issues in hemophilia at a 101 level and the importance of these issues to nonclinical staff.

• Brenda Riske, MS, MBA, MPA
• Regina Butler, RN
• Jim Munn, RN, MS

January 30, 2015

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

18CE046 - HTC Multidisciplinary Team: Roles and Responsibilities

This online learning activity aims to enable learners from the federally-recognized U.S. Hemophilia Treatment Center Network (USHTCN) to develop competencies regarding the roles and responsibilities of members of the core team and extended multidisciplinary team for hemophilia comprehensive care, as outlined in recommendations by the Medical and Scientific Advisory Council (MASAC) and guidelines from the National Hemophilia Foundation and McMaster University.

• Identify roles and responsibilities of members of the HTC multidisciplinary hemophilia comprehensive care team as designated in formal guidance from the National Hemophilia Foundation (NHF) and McMaster University.

Clinical staff employed within the U.S. federally recognized hemophilia treatment center (HTC) network who wish to learn more about the roles and responsibilities of members of the multidisciplinary hemophilia comprehensive care team
Non-clinical HTC staff who wish to enhance their knowledge of the HTC multidisciplinary team

This Module will introduce MASAC Document #132, provide an overview of the roles of core members of the comprehensive care team, and introduce extended multidisciplinary team members.

• Susan Cutter, MSW, LCSW, MPA
• Karen Droze, MS
• Ann Forsberg, MA, MPH
• Nicole Hroma, PT
• Susan Zappa, RN-BC, CPN
• Natalie Duncan, MPH

April 3, 2018

5:00 PM Eastern, April 3, 2019

The estimated time to complete this activity is 30 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is provided for 0.5 contact hours under ANCC criteria.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

17CE071 - Physical Therapy in the Care of Persons with Hemophilia

The purpose of this activity is to enable the learner to describe the specific responsibilities and concerns of physical therapists performing as core members of the hemophilia comprehensive team.

• Validate physical therapy as a key discipline in the management of hemophilia,
• Evaluate the physical therapist's role within the HTC's comprehensive team,
• Identify musculoskeletal complications of hemophilic bleeding,
• Explain physical therapy interventions for acute bleeding disorders,
• Assess physical therapy management for chronic musculoskeletal complications of hemophilia,
• Recommend various types of physical activity and sport selection for persons with bleeding disorders

Physical therapists in the U.S. hemophilia treatment center (HTC) network that engage in physical therapy management of individuals with hemophilia or have a basic knowledge of hemophilia and comprehensive care.

Nurses in the U.S. HTC network who participate in multidisciplinary comprehensive care programs and thus require familiarity with the impact of hemophilia on joint health and the physical therapy considerations that are critical to caring for this population.

Participants are assumed to be licensed nurses and physical therapists with fundamental musculoskeletal and neurological knowledge.

This module will describe the roles and responsibilities of a physical therapist as a key member of the hemophilia comprehensive team. The process of musculoskeletal bleeding will be illustrated and complications arising from hemarthroses will be described. General activity considerations, activity selection and activity ratings will be provided.

• Stacie Akins, PT, MHS
• Sherry Herman-Hilker, PT, MS
• Joel Lee, PT
• Nicole Hroma, PT

July 27, 2017

5:00 P.M. Eastern, July 27, 2018

The estimated time to complete this activity is 90 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

This activity is provided for 1.5 contact hours under ANCC criteria.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education has been awarded Accreditation with Distinction, the highest recognition awarded by the American Nurses Credentialing Center's Accreditation Program. This distinction is valid through 2020.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

16CE092 - Products Licensed in the U.S. to Treat Bleeding Disorders

The purpose of this learning activity is to explore the indications and usage of products licensed in the United States for the treatment of hemophilia and other rare bleeding disorders.

Educational Objectives for Nurses and Pharmacists

• Differentiate plasma-derived clotting factor products from recombinant clotting factor products
• Identify clotting factor concentrates used to treat persons with hemophilia and other rare bleeding disorders in the United States
• Describe adjuvant therapies available to treat bleeding

Educational Objectives for Pharmacy Technicians

• Discuss the history of plasma-derived and recombinant hemophilia treatment products in the United States, specifying the decade in which these two types of products became commercially available and the primary difference in the production process
• State one characteristic of 4th generation clotting factor products that differentiates them from earlier generations
• List five treatment clotting factor or adjuvant products available to treat persons with hemophilia A or hemophilia B in the United States

• Nurses
• Pharmacists
• Pharmacy technicians
• Other staff working in the federally recognized U.S. Hemophilia Treatment Center Network (USHTCN) interested in learning more about products licensed in the US for the treatment of hemophilia and other rare bleeding disorders

This module will present the differences between plasma derived and recombinant products. Hemophilia A, Hemophilia B, von Willebrand Disease and other rare forms of bleeding disorder treatments will be presented. Different generations of products will be laid out so the learner has a greater understanding of the history of products as well.

• Jim Munn, RN-BC, BS, BSN, MS

July 26, 2017

5:00 PM Eastern, July 26, 2018

The estimated time to complete this activity is 45 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• For Pharmacists and Pharmacy Technicians to receive credit: upon successful completion of the post-test you must complete an evaluation survey providing your NABP eProfile ID number, date of birth, the date you completed the activity, and whether you are a Pharmacist or Pharmacy Technician. You must also email this information to sstrole@iuhealth.org.
• Nor Nurses and other learners to receive credit: upon successful completion of the post-test your certificate of completion will be available to print or save.

Accredited for KNOWLEDGE BASED CE credit hour(s) (1.0 CEU) for pharmacists and pharmacy technicians

Indiana University Health is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Pharmacist UAN: 0855-000-17-033-H04-P. Pharmacy Technician UAN: 0855-000-17-033-H04-T. The home study component’s initial release date is July 15, 2017 and will expire on July 15, 2020. Please contact IU Health at 317-962-9089 if you have questions regarding CE credit.

This activity is provided for 0.75 contact hours under ANCC criteria.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education has been awarded Accreditation with Distinction, the highest recognition awarded by the American Nurses Credentialing Center's Accreditation Program. This distinction is valid through 2020.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

18CE045 - U.S. Hemophilia Treatment Center Network: The Big Picture

The purpose of this online educational module is to familiarize staff of the 140+ federally recognized U.S. hemophilia treatment centers (HTCs) with the network to which those HTCs belong. The organization of the network has allowed the development and refinement of the hemophilia comprehensive care model, associated with significant reduction in hemophilia morbidity and mortality. Funding sources, data collection efforts, and research findings are described.

• Describe the organization of the U.S. hemophilia treatment center (HTC) network
• Examine the key components of the hemophilia comprehensive care model
• Evaluate significant sources of funding for the U.S. HTC network
• Explain the importance of HTC data collection
• Identify three ongoing data collection systems
• List three important research findings regarding the U.S. HTC network

Nurses, physicians, physical therapists, social workers and other clinical staff within the U.S. HTC network who wish to learn more about the organization, services provided, funding, and outcomes of the network. Additional HTC staff who wish to enhance their knowledge of the U.S. HTC network

This module will describe the establishment of specialized care for hemophilia by Biggs, McFarlane, and Kasper and illustrate the placement of HTCs and regions on a U.S. map. It will also show HTC population by diagnosis since 1990 and provide the MASAC Standards and Criteria for care at HTCs. This module will describe characteristics of HTCs and provide a timeline of the U.S. HTC Network. This module will then list nine components of the comprehensive care model, identify comprehensive care team members, define and discuss family-centered care, discuss comprehensive care outreach, identify goals of comprehensive care clinic, and discuss HTC interactions with the patient. This module will also identify HTC funding sources, explain the Veteran’s Health Care Act 340B Factor Programs, graph the federal funding structure, discuss the role of partnerships with consumers, not in funding, but in supporting the network, discuss the core outcome measures of the Maternal and Child Health Bureau, and introduce ATHN and its activities. It will describe the purpose of the CDC Hemophilia Surveillance grant to support public health surveillance, prevention of complications of blood disorders, and blood safety, introduce the primary repositories for HTC data collection, and define the purpose of HTC data collection. This module will introduce Community Counts Surveillance Project, ATHNdataset (Clinical Manager), and Hemophilia & Thrombosis Data Set (HTDS). It will expand on discussion of HTDS, define current U.S. HTC Network research and data priorities, and explain the CHOICE Project. Finally, the module will review the outcomes of HTC care from the 6-state surveillance study, define health outcomes measurement and its purpose, and recall Universal Data Collection (UDC) System study purpose, enrollment, and findings.

• Susan Cutter, MSW, LCSW, MPA
• Karen Droze, MS
• Ann Forsberg, MA, MPH
• Nicole Hroma, PT
• Susan Zappa, RN-BC, CPN
• Natalie Duncan, MPH

March 5, 2018

5:00 PM Eastern, March 5, 2019

The estimated time to complete this activity is 30 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.5 contact hours under ANCC criteria.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

17CE087 - Laboratory Measurements of Hemostasis: Patient Sample Series

The purpose of this activity is to enable the learner to gain detailed knowledge about the basic laboratory screening tests used in hemophilia, including platelet count and size, activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT), fibrinogen assay, and mixing studies. The activity also provides information about the diagnoses made from these screening tests and provides the learner the opportunity to test his or her knowledge through case studies.

• Explain basic laboratory screening tests uses in hemostasis.
• Discuss the diagnoses made from hemostasis screening tests.
• Utilize laboratory screening tests to determine possible diagnoses on unknown samples.

Nurses, pharmacists, pharmacy technicians, and other staff working in the U.S. Hemophilia Treatment Center network interested to learn more about the treatment of bleeding disorders.

This module is an interactive platform that explains different laboratory screening tests used in hemostasis included Platelet count and size, Activated partial thromboplastin time (APTT), Prothrombin time (PT), Thrombin time (TT), Fibrogen assay, and Mixing studies. The activity then provides learners the opportunity to apply knowledge by reviewing diagnoses made from hemostasis screening tests in 5 different patient samples, and will show learners how to utilize laboratory screening test to determine diagnoses on unknown samples.

• Linda Jacobson, MT(ASCP)
• Brenda Riske, RN, MSN, MBA, MPA
• Susan Zappa, RN-BC, CPN

August 28, 2017

5:00 PM Eastern August 28, 2018

The estimated time to complete this activity is 30 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

This activity is provided for 0.5 contact hours under ANCC criteria.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education has been awarded Accreditation with Distinction, the highest recognition awarded by the American Nurses Credentialing Center's Accreditation Program. This distinction is valid through 2020.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

18CE070 - Nutritional Considerations in Common Comorbidities of Hemophilia

This online learning activity aims to enable learners from the federally-recognized U.S. Hemophilia Treatment Center Network (USHTCN) to develop competencies regarding the roles and responsibilities of the registered dietitian nutritionist on the multidisciplinary comprehensive care team, and to gain familiarity with nutritional considerations in common comorbidities of hemophilia, to include hepatitis C, HIV, iron deficiency anemia, osteoporosis, obesity, and dyslipidemia.

• Discuss the roles and responsibilities of the Registered Dietitian Nutritionist on the hemophilia comprehensive care team
• Examine the components of the nutrition assessment administered by the HTC Registered Dietitian Nutritionist
• Evaluate nutrition objectives and dietary interventions for common comorbidities of hemophilia
• Identify important considerations and discussion points for persons with hemophilia regarding dietary supplements

Registered dietitian nutritionists, nurses, physical therapists, social workers, and other members of the multidisciplinary comprehensive care team at U.S. Hemophilia Treatment Centers (HTCs) who are involved in or support the nutritional health of patients

At HTCs, patients may experience nutritional challenges related to hepatitis C, HIV, iron deficiency anemia, osteoporosis, overweight and obesity, and dyslipidemia. There is an important role for a registered dietitian or someone serving in this capacity to promote optimal nutritional health, provide nutrition services to both pediatric and adult patients by making appropriate nutrition recommendations depending on an individual's needs, and provide ongoing support until an individuals' nutrition goals are met. This module seeks to address this need.

• Tina Willis, MA, RDN

May 3, 2018

5:00 PM Eastern, May 3, 2019

The estimated time to complete this activity is 45 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.75 contact hours under ANCC criteria.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

17CE106 - Clinical Management of Inhibitors Module 2: Treatment of Bleeding Episodes.

The purpose of this activity is to enable the learner to deepen their knowledge concerning treatment of bleeding episodes in persons with hemophilia and inhibitors, the use of prophylactic treatment in these individuals, and surgical management of these individuals, with the goal of improving care quality, consistency, and outcomes for persons with hemophilia and inhibitors.

• Describe considerations that influence treatment options
• Evaluate the treatment options for management of acute bleeds in individuals with inhibitors
• Describe the potential use of prophylactic therapy in individuals with congenital hemophilia and inhibitors
• Review the use of bypassing agents in the surgical setting for inhibitor patients
• Identify psychosocial issues related to inhibitors

This module is intended for nursing professionals and other health care providers at hemophilia treatment centers (HTCs) who are involved in the management of individuals with congenital hemophilia who have inhibitors. The module is also intended for health care professionals involved in the management of individuals with acquired inhibitors directed at factor VIII (acquired hemophilia).

Inhibitor development is one of the most serious and costly complications of hemophilia. Standard factor replacement therapy is often no longer possible, which complicates the treatment of bleeds and results in significant morbidity. A recent review by investigators from the US Centers for Disease Control and Prevention (CDC) and the Hemophilia Treatment Center Network (HTCN) found that males with severe hemophilia A and a current inhibitor are at increased risk of death. Definitive guidelines for the clinical management of inhibitors are sparse, as are guidelines for immune tolerance induction to eradicate the inhibitors. Nurses need more education on the risk factors, clinical presentation and impact of inhibitors. In particular, nurses need practical education on clinical management of patients with inhibitors to factor VIII or factor IX. In addition, nurses at hemophilia treatment centers also are responsible for treating individuals with acquired hemophilia, a very rare but potentially life-threatening condition. The risk factors, clinical manifestations and treatment of acquired hemophilia are distinct from those of inhibitors in congenital hemophilia, but education on acquired hemophilia is limited.
This series of modules seeks to address these educational gaps. Module 1 covers the risk factors for and classification of inhibitors and includes case scenarios to describe how FVII, FIX, and acquired FVIII inhibitors may present in the clinical setting; Module 2 reviews the strategies to treat bleeding episodes in patients with inhibitors; Module 3 focuses on the immune tolerance induction regimens that may be used to eradicate inhibitors.

• Jennifer Maahs, RN-BC, MSN, PNP
• Reviewer: Jayson Stoffman, MD, FRCP(C)

November 28, 2017

5:00 PM Eastern, November 27, 2018

The estimated time to complete this activity is 45 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.75 contact hours under ANCC criteria.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education has been awarded Accreditation with Distinction, the highest recognition awarded by the American Nurses Credentialing Center's Accreditation Program. This distinction is valid through 2020.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation (ANCC) through the joint providership of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education (UNMC CON CNE) (provider) and Partners in Bleeding Disorders Education.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

17CE056 - Psychosocial Considerations in Bleeding Disorder Care: Aging with Hemophilia

The purpose of this online learning activity is to explore the psychosocial considerations of aging with hemophilia. The burden of chronic disease is increasing among persons aged 65+ in the United States. As hemophilia treatment has improved over the decades, we now see the resultant population explosion in elderly persons with hemophilia. Chronic diseases are prevalent in the elderly hemophilia population just as in the elderly general population. After exploring increased life expectancy and prevalence of chronic disease among older adults with hemophilia, this activity will assess psychosocial considerations in managing care for elderly persons with hemophilia, incorporating practical psychosocial assessment strategies to utilize in the HTC environment to optimize patient care in this population. Finally, this activity will make use of case studies to apply recommended strategies in persons with hemophilia.

• Describe the increasing burden of chronic disease among persons aged 65 and over in the United States
• Review the evolution of hemophilia treatment and the associated increase in life expectancy among PWH
• Evaluate the prevalence of chronic conditions among elderly PWH
• Assess psychosocial considerations in managing care for elderly PWH
• Incorporate practical psychosocial assessment strategies to utilize in the HTC environment to optimize patient care among elderly PWH
• Apply recommended assessment strategies to case studies involving elderly PWH

This learning activity is targeted toward social workers, nurses and other members of the multidisciplinary team at federally-recognized hemophilia treatment centers (HTCs) who routinely encounter psychosocial issues related to aging in persons with hemophilia (PWH).

This program will review the different options for hemophilia treatment throughout history and how the current treatments can affect the elderly population with hemophilia. Psychosocial strategies will be presented to help professionals work with an aging hemophilia population.

• Ellen Kachalsky, MSW, LMSW, ACSW, CCM
• Colleen Joiner, LMSW

June 30 2017

5:00 PM Eastern, June 30, 2018

The estimated time to complete this activity is 75 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 80% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

This activity is provided for 1.25 contact hours under ANCC criteria.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education has been awarded Accreditation with Distinction, the highest recognition awarded by the American Nurses Credentialing Center's Accreditation Program. This distinction is valid through 2020.

This program is Approved by the National Association of Social Workers (Approval # 886604222-2583) for 1.0 continuing education contact hours.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

17CE070 - Clinical Management of Inhibitors Module 3: Immune Tolerance Induction (ITI)

The purpose of this activity is to sharpen clinical knowledge and skills relating to the nursing role in eradication of inhibitory antibodies to factor VIII and IX via immune tolerance induction therapy.

• Define immune tolerance induction, or ITI
• Describe the prognostic factors for the response to ITI and the general predictors of ITI success
• Review the most common ITI protocols used to eradicate inhibitors
• Describe the use of immunomodulating agents in ITI protocols

This learning activity is intended for nursing professionals and other health care providers at hemophilia treatment centers (HTCs) who are involved in the management of individuals with congenital hemophilia who have inhibitors.

Inhibitor development is one of the most serious and costly complications of hemophilia. Standard factor replacement therapy is often no longer possible, which complicates the treatment of bleeds and results in significant morbidity. A recent review by investigators from the US Centers for Disease Control and Prevention (CDC) and the Hemophilia Treatment Center Network (HTCN) found that males with severe hemophilia A and a current inhibitor are at increased risk of death. Definitive guidelines for the clinical management of inhibitors are sparse, as are guidelines for immune tolerance induction to eradicate the inhibitors. Nurses need more education on the risk factors, clinical presentation and impact of inhibitors. In particular, nurses need practical education on clinical management of patients with inhibitors to factor VIII or factor IX. In addition, nurses at hemophilia treatment centers also are responsible for treating individuals with acquired hemophilia, a very rare but potentially life-threatening condition. The risk factors, clinical manifestations and treatment of acquired hemophilia are distinct from those of inhibitors in congenital hemophilia, but education on acquired hemophilia is limited.
This series of modules seeks to address these educational gaps. Module 1 covers the risk factors for and classification of inhibitors and includes case scenarios to describe how FVII, FIX, and acquired FVIII inhibitors may present in the clinical setting; Module 2 reviews the strategies to treat bleeding episodes in patients with inhibitors; Module 3 focuses on the immune tolerance induction regimens that may be used to eradicate inhibitors.

• Jennifer Maahs, RN-BC, MSN, PNP
• Jayson Stoffman, MD, FRCP(C)

July 19, 2017

5:00 PM, Eastern, July 19, 2018

The estimated time to complete this activity is 45 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

This activity is provided for 0.75 contact hours under ANCC criteria.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education has been awarded Accreditation with Distinction, the highest recognition awarded by the American Nurses Credentialing Center's Accreditation Program. This distinction is valid through 2020.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

17CE054 - Psychosocial Considerations in Bleeding Disorder Care: Birth to Preadolescence

This program will provide an introduction to the psychosocial considerations that are relevant when working with infants through preadolescents who have hemophilia or other bleeding disorders and their families.

• Examine the psychosocial reactions of a family experiencing a new bleeding disorder diagnosis
• Define the developmental stages of childhood, including infancy through preadolescence, as experienced by children with bleeding disorders
• Evaluate the influence of the developmental stages of childhood on parenting a child with a bleeding disorder
• Apply practical social work assessment strategies and interventions in the Hemophilia Treatment Center (HTC) environment

This learning activity is targeted toward social workers, nurses, and other health care professionals in the federally recognized U.S. hemophilia treatment center network (USHTCN) interested in learning more about the psychosocial considerations of care for children and preadolescents with bleeding disorders

This program will cover the psychosocial impact of receiving a bleeding disorder diagnosis and the impact on family members and those patients from birth to preadolescence. In addition, it will outline strategies and interventions that can be undertaken.

• Colleen Joiner, LMSW
• Leslie Johns McGeady, MSW
• Dawn von Mayrhauser, MSW, LCSW

June 30, 2017

5:00 PM Eastern, June 30, 2018

The estimated time to complete this activity is 60 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 80% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

This activity is provided for 1.0 contact hours under ANCC criteria.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education has been awarded Accreditation with Distinction, the highest recognition awarded by the American Nurses Credentialing Center's Accreditation Program. This distinction is valid through 2020.

This program is Approved by the National Association of Social Workers (Approval # 886604222-2149) for 1.0 continuing education contact hours.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

17CE072 - Clinical Management of Inhibitors Module 1: Risk Factors and Initial Presentation

The purpose of this activity is to enable the learner to describe the risk factors for, the clinical presentation of inhibitors as they develop in the body, and how this relates to various forms of hemophilia.

• Define inhibitors in hemophilia
• Describe the clinical and psychosocial impact of inhibitors to factors VIII and IX
• Discuss clinical detection of an inhibitor
• Explore the epidemiology of inhibitors in hemophilia, including incidence and prevalence
• Review the risk factors for inhibitor development
• Differentiate inhibitor development in congenital hemophilia versus acquired hemophilia

This module is intended for nursing professionals and other health care providers at hemophilia treatment centers (HTCs) who are involved in the management of individuals with congenital hemophilia who have inhibitors. The module is also intended for health care professionals involved in the management of individuals with acquired inhibitors directed at factor VIII (acquired hemophilia).

Inhibitor development is one of the most serious and costly complications of hemophilia. Standard factor replacement therapy is often no longer possible, which complicates the treatment of bleeds and results in significant morbidity. A recent review by investigators from the US Centers for Disease Control and Prevention (CDC) and the Hemophilia Treatment Center Network (HTCN) found that males with severe hemophilia A and a current inhibitor are at increased risk of death. Definitive guidelines for the clinical management of inhibitors are sparse, as are guidelines for immune tolerance induction to eradicate the inhibitors. Nurses need more education on the risk factors, clinical presentation and impact of inhibitors. In particular, nurses need practical education on clinical management of patients with inhibitors to factor VIII or factor IX. In addition, nurses at hemophilia treatment centers also are responsible for treating individuals with acquired hemophilia, a very rare but potentially life-threatening condition. The risk factors, clinical manifestations and treatment of acquired hemophilia are distinct from those of inhibitors in congenital hemophilia, but education on acquired hemophilia is limited.
This series of modules seeks to address these educational gaps. Module 1 covers the risk factors for and classification of inhibitors and includes case scenarios to describe how FVII, FIX, and acquired FVIII inhibitors may present in the clinical setting; Module 2 reviews the strategies to treat bleeding episodes in patients with inhibitors; Module 3 focuses on the immune tolerance induction regimens that may be used to eradicate inhibitors.

• Jennifer Maahs, RN-BC, MSN, PNP
• Reviewer: Jayson Stoffman, MD, FRCP(C)

July 25, 2017

5:00 pm Eastern, July 25, 2018

The estimated time to complete this activity is 60 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

This activity is provided for 1.0 contact hours under ANCC criteria.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education has been awarded Accreditation with Distinction, the highest recognition awarded by the American Nurses Credentialing Center's Accreditation Program. This distinction is valid through 2020.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

17CE055 - Psychosocial Consideration in Bleeding Disorder Care: Lifespan Development and Transitions

This module aims to enable the learner to enhance understanding of life skills, transitioning, and considerations relevant when working with persons with bleeding disorders throughout the lifespan.

• Define the concept of lifespan development
• Identify challenges to successful lifespan development in persons with bleeding disorders by influencing factors such as developmental stage, family dynamics, and cultural practices or beliefs
• Explore interventions that can be applied in the HTC at different stages in the lifespan development process to support positive transition
• Review available guidelines to assist in developing appropriate care plans and interventions in lifespan development and transition

Social workers, nurses and other healthcare professionals at hemophilia treatment centers (HTCs) who are involved in helping patients learn the necessary life skills to successfully manage lifespan transitions related to their health care.

This program will identify challenges to successful lifespan development throughout multiple stages of life, from birth to 5 years of age to middle adult to senior years. Intervention options that the HTC can implement throughout the varying stages of life will be explored as well. Lastly the NHF Transition Guidelines will be presented and reviewed.

• Gail Jordan, MSW, LCSW
• Bob Louden, MSW, LCSW
• Ashley Parmerlee, MSW, LSW
• Brittany Savage, MSN, AGPCNP-BC

July 31 2017

5:00 PM Eastern, July 31, 2018

The estimated time to complete this activity is 45 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 80% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.75 contact hours under ANCC criteria.

---

This program is Approved by the National Association of Social Workers (Approval # 886604222-5098) for 1.0 continuing education contact hours.

Contact Information

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

System Requirements

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.